A system for transformation of rat liver cells in vitro by acute treatment with aflatoxin. by Sinha, S. et al.
Br. J. Cancer (1987), 55, 595 598
© The Macmillan
A system for transformation of rat liver cells in vitro by acute treatment
with aflatoxin
S. Sinha*, L.J. Hockin & G.E. Neal
Section ofBiological Chemistry, Medical Research Council Toxicology Unit, Woodmansterne Road, Carshalton, Surrey SM5
4EF, UK.
Summary Aflatoxin B, (AFB,) induced rat liver cancer is a well studied system of hepatocarcinogenesis.
AFBI has also been used to transform cultured rat liver derived cells in vitro. Cells in culture often have a
reduced capacity to metabolise the AFB, to its active metabolite, and often prolonged periods of exposure to
the toxin have to be employed, with a long latency in the appearance of transformed cells in culture. We
report here the transformation of a rat liver derived cell line by acute treatment with AFB . An extrinsic
metabolising system of quail microsomes, which convert AFB1 to its epoxide form with high efficiency, was
used to activate the AFB,. A dose dependent cytotoxicity was obtained and neoplastic transformation was
seen in the higher doses used. The enzyme GGT which has strong association with liver cell transformation
both in vivo and in vitro was also elevated in the treated cells.
Aflatoxins are fungal toxins which have been implicated in
human liver cancer. There is an extensive array of rat liver
carcinogenesis systems to elucidate the steps involved in the
development of neoplasia (Newberne et al., 1973, Kalengayi
et al., 1975). Transformation of liver cells by aflatoxin in
tissue culture is complicated by the requirement for
metabolic activation of the toxin (Campbell & Hayes, 1976).
Primary cultures of hepatocytes lose their ability to
metabolise aflatoxin to its active form by a cytochrome P-
450 mediated pathway within 48 h in culture (Guzelian et al.,
1977) and so far there have been no reports of the
transformation of non-dividing hepatocyte cultures in vitro
by exposure to aflatoxin. Continuously dividing cell lines are
more susceptible to malignant transformation than primary
cultures, and have been used to study the effects of a variety
of carcinogens. Non-transformed, continuously dividing cell
lines arise spontaneously from primary cultures of rat liver
cells. They are non-tumorigenic in syngeneic hosts and in
athymic nude mice, and lack the biochemical characteristics
of mature rat hepatocytes. It is hypothesised that these cell
lines arise from a population of precursor cells in the liver
(Grisham, 1980).
BL8 is an undifferentiated untransformed cell line arising
spontaneously from cells isolated from the liver of an adult
male Fischer rat (Manson et al., 1981). It has the ultra-
structural features of an epithelial cell. After transfor-
mation by activated ras oncogenes it shows the induction
of gamma glutamyl transferase, a marker of liver cell trans-
formation and is tumorigenic in nude mice. Its tumours
in nude mice show a phenotypic spectrum ranging from
undifferentiated anaplastic tumours to well defined epithelial
cell malignancies with acini and ducts, thus covering the
tumour types seen during in vivo rat hepatocarcinogenesis
(Sinha et al., submitted for publication).
In this report we describe the transformation of BL8 cells
by acute exposure to aflatoxin. The BL8 cell line, in
common with other rat liver derived cell lines, has a low
capacity to metabolise aflatoxin B1 (AFB1) to its active
metabolite, though metabolism by other cytochrome P-448
mediated pathways may occur (Manson et al., 1981).
Previously transformation of such cell lines with AFB1 has
been achieved by prolonged exposure to the carcinogen over
a period of several weeks (Williams et al., 1973). The use of
a metabolising system of quail microsomes coupled with the
partial synchronisation of cells in late G1 and S-phase
resulted in the transformation of cells after an acute
treatment with the toxin. Tissue culture conditions after the
treatment provided a non-selective environment for the
growth of the cells, and were thus better suited for the study
of the acquired changes in phenotype.
Materials and methods
BL8 cells were grown in Williams E (WE) medium
supplemented with 5% foetal calf serum and 2mM
glutamine. Cells were treated with AFB1 along with the
quail microsomes metabolising system at the late G1 and S-
phase of the cell cycle. A partial synchronisation was
achieved by the subculturing (split of 1:4) of a confluent,
contact inhibited culture, as described by Skilleter et al.
(1983). It has been shown (Skilleter et al., 1983) that the
confluent population of such cells consists of a majority of
cells in the G1 phase. Sixteen hours after subculture, the cells
start entering the S-phase, and by 20h, a majority of cells
are in S-phase. Treatment of cells with AFB1 was started
16h after subculture. Three treatments of 30min duration
were given with a 2h interval between the treatment. This
was designed to catch most cells in the late G1 and S-phase
of the cell cycle, the short spans of exposure to AFB1 and
microsomes being necessary to avoid the immediate
detrimental effects of the experimental conditions. To treat
with AFB1 the medium was removed and cells washed with
Hanks Balanced Salt Solution (HBSS). Incubation was with
AFB1 at the desired concentration in 10ml of HBSS per
petri dish of 10cm diameter. The concentration of DMSO
was kept constant at 0.05% in all experiments. One hundred
pl of quail microsomes, at a concentration of 6 mg
proteinml- 1, were used per petri dish. Quail microsomes
were prepared by the method of Neal et al. (1986). An
external NADPH generating system was also added, which
consisted of 0.5mgNADP, 1.66mg glucose - 6 phosphate
and 0.08 units glucose 6 phosphate dehydrogenase in a
volume of 100 pl for each petri dish. After 30min incubation,
cells were washed and covered with 10ml of WE medium
with 5% FCS. After three such treatments, medium was
changed, and the cells maintained in the same way as the
untreated BL8 cells.
Cytotoxicity was assessed by counting the numbers of cells
attached to petri dishes 48 h after treatment. Figures from
treated dishes were recorded as a percentage of the numbers
of cells in plates treated with DMSO alone. Assays of GGT
were performed by the methods of Smith et al. (1979). Nude
mouse tumorigenicity was seen after- injecting with 5 x 106
cells subcutaneously in the flanks. Anchorage independent
growth was seen by the ability to form colonies in a
*On research leave from the Indian Council of Medical Research.
Correspondence: S. Sinha.
Received 8 September 1986; and in revised form, 27 November 1986.
C The Macmillan Press Ltd., 1987 Br. J. Cancer (1987), 55, 595-598596 S. SINHA et al.
suspension in 0.33% agar on a 0.5% agar base, as described
previously (Sinha et al., 1986).
Treatment of primary cultures of rat hepatocytes was on
similar lines. Hepatocytes were isolated from livers of normal
male Fischer rats by collagenase perfusion (Berry & Friend,
1969). They were treated by Epidermal Growth Factor
(EGF) at a concentration of lOngml-1. They were treated
with AFB1 in a protocol similar to that for the treatment of
BL8 cells. There were three treatments of 30min starting
16h after the addition of EGF in medium. Since 3 one day
old primary cultures of rat hepatocytes retain the capacity to
metabolize AFB1 no extrinsic metabolizing system was
added. The hepatocytes were in late G1/S-phase at the time
of treatment with AFB1 (Walker et al., unpublished
observations).
Results
Acute exposure to AFB1 resulted in a dose dependent
cytotoxicity. Immediately after treatment some evidence of
toxicity was seen in the higher doses used (5 and 10Mgml-1).
However, as seen by the number of cells attached to the petri
dish 48 h after treatment, all doses used were cytotoxic to the
cells and the cytotoxicity was dose dependent
(Table I). While the cells dosed with lower doses of aflatoxin
(0.5 and 1pgml-1) recovered earlier and grew to a mono-
layer in 1-2 weeks, cells dosed with higher concentrations
of the toxin took longer to recover. In most cases they were
overgrown with cells of a strikingly altered morphology
(Figure 1), spindle shaped or rounded which did not show
contact inhibition. While there were areas of altered cellular
morphology in all treatments, with lower doses the general
appearance of the cells was maintained. Populations of cells
from the treated petri dishes were tested for tumorigenicity
and anchorage independent growth and levels of the
enzyme GGT were assayed. They were further cloned out
in soft agar and by dilutional cloning, and some morpho-
logically altered areas were picked up by cloning with a
steel ring. Tumorigenicity, growth properties and GGT







Figure 1 (a) Untreated BL8 cells; (b) BL8 cells after treatment.
levels were assayed in the cloned cells as well. A rise in the
enzyme GGT accompanied exposure to all levels of AFB1
(Table II). This was not dose dependent and while all the
populations of cells showing malignant transformation had
a high level of the enzyme, it was also elevated on treat-
ment with 0.5 and lgml-1 AFB1 which did not produce
mouse tumorigenicity and anchorage independent growth.
The correlation between anchorage independent growth and
tumorigenicity was high though not absolute and in one
experiment with cells treated with 5 gml-1 of AFB1 the
resulting population of cells did not grow in soft agar,
though nude mouse tumours developed with a short latency
period.
Tumour bearing mice were sacrificed when the neoplasms
were l1.5cm in diameter. Tumours were of a mixed fibro-
Table II GGT activity, nude mouse tumorigenicity and anchorage independent growth
after treatment with AFB1. GGT activity is expressed in nmol substrate mg-1 protein
min-
Anchorage
Dose of Nude mouse independent
AFB1 Expt. no. GGT activity tumorigenicity growth
0 Control Not detectable 0/3 -ve
0.5 L 0.5 2.2 0/3 -ve
1 L 1.0 2.4 0/3 -ve
5 L 5 4.8 3/3 (3wks) +ve
5 N 1.2 3/3 (3wks) +ve
5 TC 1.05 3/3 (3wks) -ve
0 1 0 T 1.7 3/3 (3wks) +ve
10 T4 5.7 3/3 (2wks) +ve
Cloned lines derived from treated cells
5 L 15 2.1 2/3 (3wks) +ve
L 19 9.1 3/3 (3wks) +ve
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sarcomatous and undifferentiated epithelial morphology,
without any defined structural components, of a type
described in literature as carcinosarcoma (Montesano et al.,
1973).
We were unable to transform any primary cultures of
hepatocytes, though dose dependent cytotoxicity of a similar
order as seen in BL8 cells was observed indicating sufficient
activation of AFB1.
Discussion
AFB1 is activated by cytochrome P-450 to form 8,9-AFB1
epoxide, a highly reactive metabolite, which can induce
mutations, chiefly G-A transitions in DNA by forming
covalent adducts with DNA. This metabolic activation of
AFB1 is critical to its mutagenicity (Foster et al., 1983) and
cell lines in culture lacking this biochemical pathway cannot
be transformed with AFB1 unless an external metabolising
system is provided. We used the rat liver derived epithelial
cell line BL8 for transforming cells with an acute exposure to
AFB . BL8 cells are immortalised and therefore sensitive to
being transformed by a single mutagenic event, a
phenomenon which can be mimicked by transformation with
a mutated ras oncogene introduced by transfection (Sinha et
al., 1986). In this aspect they are much more amenable to
the carcinogenic activity of aflatoxin than primary rat
hepatocyte cultures. We were unable to transform primary
cultures of hepatocytes. DNA synthesis was induced in those
non-dividing primary hepatocyte cultures by Epidermal
Growth Factor and they were treated with AFB1 in late
Gl/S-phase in a protocol similar to the transformation of
BL8 cells. Primary hepatocytes, after 16h in culture, retain
sufficient endogenous metabolism of the procarcinogen to its
active form, and no extrinsic metabolising system was
provided. In the case of AFB1 metabolism, where
cytotoxicity shows a direct relationship with 8-9 epoxide
formation and DNA binding, evidence of cytotoxicity in the
primary hepatocyte culture was taken as an indicator of
production of the ultimate carcinogen. In spite of obvious
dose-dependent cytotoxicity, we could obtain no transformed
cell lines as could be obtained from BL8 cells.
Previous work from this laboratory has shown that the
rate of microsomal metabolism of AFB1 by male quail is
higher than the corresponding fraction from the rat liver and
also a much higher proportion of the metabolism proceeds
through 8,9-AFB1 epoxidation in the quail (Neal et al.,
1986). It was therefore decided to use quail microsomes in
preference to the S-9 metabolic activation system which has
been used to activate AFB1 for Ames testing and also for
the transformation of C3H/IOT- cells (Billings et al., 1985).
Cells were treated in the late GI and S-phase of the cell
cycle which is very sensitive to the action of carcinogens
(Marquardt, 1974; Milo & DiPaolo, 1978).
On treatment with carcinogens there was a dose dependent
cytotoxic effect, which was much more at 5 and 10pgml-1
AFB . This reflects the efficacy of the microsomal meta-
bolising system because BL8 cells, not having the relevant
biochemical pathways, are not susceptible to the action of
the procarcinogen alone. Neoplastic transformation as seen
by the property of mouse tumorigenicity was evident at
higher doses (5 and 10jigml-1), where cell survival was less
than 1% of the original population.
Carcinogens can be cytotoxic by a variety of mechanisms
because of the multiple ways they can cause cell death e.g.
the ubiquitous macromolecular binding of AFB,. Cell trans-
formation is a more specific and rare event, reflecting the
binding of the carcinogen to a site or limited number of
sites in the DNA. For the carcinogen N-methyl-N'-nitro-
N-nitrosoguanidine, it has been shown that while
cytotoxicity is linearly related to dose, the probability of
transformation among survivors increases logarithmically
(Grisham et al., 1980b). While the exact kinetics for AFB1
have not been worked out, a similar behaviour would explain
the detection of transformed BL8 cells at concentrations
showing the highest degrees of cytotoxicity.
The tumour type produced by AFB1 transformed BL8
cells is consistent with the results obtained previously by
workers using cultured rat liver derived epithelial cell lines
for transformation by different carcinogens. In spite of the
cell lines being epithelial by established morphological and
ultrastructural criteria, most investigators report the presence
of sarcomatous tumours, and tumours of a mixed histo-
pathology, and less frequently adenocarcinomas (Borek,
1980). Though BL8 cells have the capacity to form differen-
tiated epithelial tumours (Sinha, et al., submitted for public-
ation), transformation by AFB1 in vitro resulted in tumours
of an undifferentiated histology.
GGT was induced throughout the dose range of AFB1
treatment, even in doses which did not cause cell trans-
formation. Its induction was not dose dependent and values
in all sets of treated cells were uniformly higher than the
parent line. We have earlier shown that GGT is induced in
cells transformed by a ras oncogene (Sinha et al., 1986).
However, the strong association of GGT with tumorigenesis
does not represent a critical requirement and the factors
involved in the induction of the enzyme point to a cellular
response rather than a change crucial to neoplasia. GGT can
influence the metabolism of AFB1 and may have a role in
the selection of cells resistant to the toxic action of the
carcinogen (Moss et al., 1984; Campbell & Hayes, 1976).
In this study cells surviving the carcinogen treatment had
increased GGT levels even though exposure was relatively
short and culture conditions did not put any selective pressure
on the survivors.
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